88 related articles for article (PubMed ID: 2170227)
1. [Prognostically relevant factors in malignant mixed Müllerian tumor].
Marth C; Koza A; Müller-Holzner E; Hetzel H; Fuith LC; Dapunt O
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):605-9. PubMed ID: 2170227
[TBL] [Abstract][Full Text] [Related]
2. Morphologic prognostic factors of malignant mixed müllerian tumor of the uterus: a clinicopathologic study of 58 cases.
Gagné E; Têtu B; Blondeau L; Raymond PE; Blais R
Mod Pathol; 1989 Sep; 2(5):433-8. PubMed ID: 2554278
[TBL] [Abstract][Full Text] [Related]
3. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.
Marth C; Windbichler G; Petru E; Dirschlmayer W; Obermair A; Czerwenka K; Müller-Holzner E; Dapunt O
Gynecol Oncol; 1997 Jan; 64(1):121-5. PubMed ID: 8995559
[TBL] [Abstract][Full Text] [Related]
4. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
5. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
6. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
7. Mixed müllerian tumors of the uterus: a clinicopathologic study.
Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):388-92. PubMed ID: 2548134
[TBL] [Abstract][Full Text] [Related]
8. Prognostic features of sarcomas and mixed tumors of the endometrium.
Peters WA; Kumar NB; Fleming WP; Morley GW
Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
[TBL] [Abstract][Full Text] [Related]
9. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy.
Kadar N; Malfetano JH; Homesley HD
Obstet Gynecol; 1992 Oct; 80(4):655-9. PubMed ID: 1407890
[TBL] [Abstract][Full Text] [Related]
10. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
11. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
[TBL] [Abstract][Full Text] [Related]
12. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
13. [Morphology and clinical aspects of malignant mixed müllerian tumors of the corpus uteri].
Kühn W; Heberling D; Höffken H; Rummel HH
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):888-91. PubMed ID: 6298053
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in adenocarcinoma of the endometrium].
Giordana C; Malinverni G; Rosmino C; Del Tetto F; Ravarino N; Sala S
Radiol Med; 1991 Mar; 81(3):342-5. PubMed ID: 2014343
[TBL] [Abstract][Full Text] [Related]
15. [Malignant mesodermal mixed tumor of the uterus--a study of 37 cases].
Zhang WH
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):378-80. PubMed ID: 1664319
[TBL] [Abstract][Full Text] [Related]
16. The importance of peritoneal cytology in endometrial carcinoma.
Harouny VR; Sutton GP; Clark SA; Geisler HE; Stehman FB; Ehrlich CE
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):394-8. PubMed ID: 3405555
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
[TBL] [Abstract][Full Text] [Related]
19. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
20. Malignant mixed mullerian tumors of the uterus. A clinicopathologic study of 9 patients.
Ruffolo EH; Metts NB; Sanders HL
Obstet Gynecol; 1969 Apr; 33(4):544-52. PubMed ID: 4304789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
